Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies

B Aydin, A Caliskan, KY Arga - EPMA Journal, 2021 - Springer
Pituitary neuroendocrine tumors (PitNETs) are the second most common type of intracranial
neoplasia. Since their manifestation usually causes hormone hypersecretion, effective …

Recent advances in proteomics and its implications in pituitary endocrine disorders

A Banerjee, A Goel, A Shah, S Srivastava - Biochimica et Biophysica Acta …, 2021 - Elsevier
Pituitary adenoma is considered as one of the most frequent intracranial tumors having
salient impact on human health such as mass effects, hypopituitarism and visual defects etc …

Clinical and proteomic-based molecular characterizations of invasive and noninvasive somatotroph PitNETs

MCLDW Sunb, ZGH Miaoa, FGY Yaoc, H Zhua - Neuroendocrinology, 2023 - karger.com
Introduction: Somatotroph pituitary neuroendocrine tumours (PitNETs) are characterized by
complex and variable biological behaviours with unpredictable patterns of growth and …

MicroRNA-146b-5p/EPHA7 axis regulates cell invasion, metastasis, proliferation, and temozolomide-induced chemoresistance via regulation of IRAK4/TRAF6/NF-κB …

X Lou, Y Cai, H Zheng, Y Zhang - 2022 - digitum.um.es
Background. Aggressive pituitary adenoma (APA) is a huge challenge for neurosurgeons.
Temozolomide (TMZ) is conventionally used in chemotherapy against APA, but acquired …

Systems Biomedicine Oriented Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors

B Aydın - 2021 - search.proquest.com
Hipofiz, beynin temel lokomotiflerinden biridir ve hipofiz nöroendokrin tümörleri (PitNET'ler)
en yaygın hipofiz hastalığıdır. Genellikle nadir neoplazmlar olarak kabul edilen ve yaşam …